Jennifer Tran, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 42 Cape Rd, Milford, MA 01757 Phone: 800-853-2288 |
Kathryn Y. Lee, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Medway Rd, Suite 204, Milford, MA 01757 Phone: 508-482-5444 Fax: 508-482-5408 |
Amy A Costa, M.D. Family Medicine - Sports Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Medway Rd Ste 204, Milford, MA 01757 Phone: 508-482-5444 Fax: 508-482-5408 |
Faheem M Farooq, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 100 Medway Road, Suite 101, Milford, MA 01757 Phone: 508-773-6288 Fax: 508-482-5430 |
News Archive
GE Healthcare and UPMC announced today that their imaging joint venture, Omnyx, is initiating clinical research testing of a breakthrough digital pathology platform that is expected to help transform the 125-year-old practice of pathologists using glass slides.
While working with parents of children with attention deficit hyperactivity disorder (ADHD) at the University at Buffalo, Gregory A. Fabiano noticed something was missing: the fathers.
Australian researchers have revealed that babies and toddlers have double the risk of head injuries than children of any other age and they have called for parents to exercise more vigilance.
LogLogic®, the leader in log and security management solutions, and the Ponemon Institute, a privacy and information management research firm, today announced results of a national survey of healthcare IT security professionals that shows patients may be surrendering their privacy as the $2.5 trillion medical industry – prompted by federal stimulus funding – pushes to accelerate the pace of digitizing health information records.
The brains of Alzheimer patients have high accumulations of the material beta-amyloid, which appear in the form of plaques. The precursors of these plaques are believed to be the underlying cause of the nerve cell loss that leads to the disruptions in memory that characterize Alzheimer's disease. The main aim of many Alzheimer therapies is therefore to inhibit the formation of beta-amyloid. Since beta-amyloid is cleaved from the so-called amyloid precursor protein (APP), scientists have focused on stopping the two enzymes that attack the precursor protein. These act like molecular scissors and cut out the beta-amyloid fragment. Blocking these scissors precludes the formation of beta-amyloid.
› Verified 1 days ago